Rita E. Numerof Ph.D.
Rita E. Numerof Ph.D.
Latest posts from Rita:
With payers increasingly demanding a differentiated clinical and economic value...
Rising drug prices have been hotly debated this year with a greater push for...
3 ideas pharma should consider in modifying their commercial approach.
Manufacturers can be a valuable partner helping IDNs create a more compelling...
How can pharma prepare for this new value-driven environment?
Reference pricing is not widely used in the US, but it has been on the radar...
There are several important questions that should be asked before entering into...
Why this trend has surfaced and key considerations for pharmaceutical companies...
In order to remain competitive, pharmaceutical companies must shift their focus...
Changes in healthcare delivery are rapidly undermining traditional...